红细胞发生

Erythrogenesis is the process by which red blood cells are produced from hematopoietic stem cells.
红细胞生成是指从造血干细胞中产生红血细胞的过程。
The study of erythrogenesis helps scientists understand how the body regulates blood production during fetal development.
红细胞生成的研究有助于科学家了解身体如何在胎儿发育期间调控血液生产。
In response to hypoxia, erythropoiesis is accelerated to increase oxygen-carrying capacity in the bloodstream.
对于低氧环境，红细胞生成会加速以提升血液中的氧输送能力。
Erythrogenesis takes place primarily in the bone marrow and spleen in vertebrates.
在脊椎动物中，红细胞生成主要发生在骨髓和脾脏。
Certain genetic mutations can impair erythrogenesis, leading to anemia or other blood disorders.
特定的基因突变可能损害红细胞生成，导致贫血或其他血液疾病。
Therapeutic strategies targeting erythrogenesis have shown promise in treating certain types of anemia.
针对红细胞生成的治疗策略在治疗某些类型的贫血方面展现出前景。
During pregnancy, increased erythrogenesis is necessary to support the growing fetus's oxygen demands.
怀孕期间，为了满足胎儿增长的氧气需求，需要增加红细胞生成。
The hormone erythropoietin plays a critical role in regulating erythrogenesis in the kidneys.
肾上腺素在调节肾脏中的红细胞生成过程中起着关键作用。
Scientists are exploring ways to enhance erythrogenesis using gene therapy to treat inherited blood disorders.
科学家正在研究利用基因疗法增强红细胞生成的方法来治疗遗传性血液病。
Monitoring erythrogenesis levels can be crucial in managing patients undergoing chemotherapy, as it may indicate potential complications.
监测红细胞生成水平对于管理化疗患者至关重要，因为它可能预示潜在并发症。